Trade PRCT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
PROCEPT BioRobotics Corporation (PRCT) is trading at US$20.59, down 0.07% today as of Aug 28, 10:20 EDT. The company has a market capitalisation of US$1.24B. Over the past 52 weeks, PRCT has traded between US$16.67 and US$42.43. On Syfe you can trade PRCT with $0 commission and add it to your watchlist.
| Previous close | US$20.60 |
|---|---|
| Market cap | US$1.24B |
| 52-week range | US$16.67 – US$42.43 |
| Volume | 1.11M |
| Exchange | US |
Add to Watchlist
Set Price Alert
PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Year: 2021
UBS Downgrades PROCEPT BioRobotics to Neutral From Buy, Cuts Price Target to $20 From $30
Jul 28, 2:06 PM · MT Newswires
PROCEPT BioRobotics Corporation (PRCT) stock is trading at US$20.59, -0.07% from the previous close of US$20.60.
The market cap for PROCEPT BioRobotics Corporation (PRCT) stock is approximately US$1.24B.
The 52-week high for PROCEPT BioRobotics Corporation (PRCT) stock is US$42.43.
The 52-week low for PROCEPT BioRobotics Corporation (PRCT) stock is US$16.67.
PROCEPT BioRobotics Corporation (PRCT) does not currently pay a dividend.
Stay on top of PRCT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
